Partners

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com

Boehringer Ingelheim

The Boehringer Ingelheim group is a research-driven company dedicated to researching and developing, manufacturing and marketing pharmaceuticals that improve health and quality of life.
Our business areas consist of Human Pharmaceuticals and Animal Health. We have more than 46,000 employees in 140 affiliated companies worldwide, research and development (R&D) facilities at six sites worldwide, and 20 production plants in 13 countries. R&D expenditure in Prescription Medicines corresponds to 22.5% of net sales.
Our headquarter is at Ingelheim, the German town where the family-owned company was founded in 1885.

Bristol Myers Squibb (BMS)

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science. For more information, please visit www.bms.com.

Genentech

Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit www.gene.com.

Genome Canada

Genome Canada is a not-for-profit organization that invests in genomics research to generate economic and social benefits for Canadians. Genome Canada builds bridges between government, academia and industry to forge a genomics-based public-private innovation enterprise focused on key life science sectors. It develops these partnerships to invest in and manage large-scale research and translate discoveries into commercial opportunities, new technologies, applications and solutions. For more information, visit www.genomecanada.ca

Janssen, Pharmaceutical Companies of Johnson & Johnson

Our strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. We leverage our world-class discovery and development expertise, and operational excellence, to bring innovative, effective treatments in five therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience and oncology. We think of the world as our laboratory and we look for innovation wherever it exists. This drives our relentless search for the best science, and our pursuit of collaborations and partnerships.

Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany was founded in Darmstadt, Germany in 1668 by Friedrich Jacob Merck, we are the world’s oldest pharmaceutical and chemical company. The Merck family has remained the majority owner of the company to this very day. Over the course of nearly 350 years, we have become a truly global company with approximately 50,000 employees in 66 countries. Our people are united by their passion for new ideas, the possibilities of technology, and the potential to make a difference in the world.

Pfizer

Pfizer is the world's leading biopharmaceutical company. Pfizer’s mission is to discover and develop innovative medicines and other products to improve the quality of life of people and animals around the world. Our diversified health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products.

Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.

Wellcome

Wellcome is the largest charity in the UK and the second largest medical research charity in the world. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. Wellcome supports public debate about biomedical research and its impact on health and well-being.

 

Funding acknowledgement

The Structural Genomics Consortium is a registered charity (no: 1097737) that receives funds from Bayer AG, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Genome Canada through Ontario Genomics Institute [OGI-196], EU/EFPIA/OICR/McGill/KTH/Diamond Innovative Medicines Initiative 2 Joint Undertaking [EUbOPEN grant 875510], Janssen, Merck KGaA (aka EMD in Canada and US), Pfizer and Takeda.

glqxz9283 sfy39587stf02 mnesdcuix8
sfy39587stf03